PDF《2013》

第1条《2013 年药剂业及毒药 ( 修订 ) ( 第3号)规例》

2013 年第

98 号法律公告 B2972 ?? Section

1 Pharmacy and Poisons (Amendment) (No.

3) Regulation

2013 L.N.

98 of

2013 B2973

2013 年第

98 号法律公告 《2013 年药剂业及毒药 ( 修订 ) ( 第3号)规例》 ( 由药剂业及毒药管理局根 《药剂业及毒药条例》 ( 第138 章)第29 条 在须经立法会批准的规限下订立 ) 1. 修订 《药剂业及毒药规例》 《药剂业及毒药规例》 ( 第138 章,附属法例 A) 现予修订,修订方 式列於第

2 及3条. 2. 修订附表1 (关於销售、供应、标签及贮存的限制根

3、

5、

6、

15、

19、

22、23 及24 条而适用的物质 ) 附表 1,A 分部―― 按笔划数目顺序加入 "克唑替尼;

其盐类 阿柏西普 芦可替尼;

其盐类". 3. 修订附表

3 ( 第9条规定仅可按照注册医生、注册牙医或注册兽 医开出的处方而以零售方式销售的物质 ) 附表 3,A 分部―― 按笔划数目顺序加入 "克唑替尼;

其盐类 阿柏西普 芦可替尼;

其盐类". L.N.

98 of

2013 Pharmacy and Poisons (Amendment) (No. 3) Regulation

2013 (Made by the Pharmacy and Poisons Board under section

29 of the Pharmacy and Poisons Ordinance (Cap. 138) subject to the approval of the Legislative Council) 1. Pharmacy and Poisons Regulations amended The Pharmacy and Poisons Regulations (Cap.

138 sub. leg. A) are amended as set out in sections

2 and 3. 2. First Schedule amended (substances to which certain restrictions with respect to the sale, supply, labelling and storage apply under regulations 3, 5, 6, 15, 19, 22,

23 and 24) First Schedule, Division A― Add in alphabetical order "Aflibercept Crizotinib;

its salts Ruxolitinib;

its salts". 3. Third Schedule amended (substances required by regulation

9 to be sold by retail only upon a prescription given by a registered medical practitioner, registered dentist or registered veterinary surgeon) Third Schedule, Division A― Add in alphabetical order "Aflibercept Crizotinib;

its salts Ruxolitinib;

its salts". 《2013 年药剂业及毒药 ( 修订 ) ( 第3号)规例》

2013 年第

98 号法律公告 B2974 Pharmacy and Poisons (Amendment) (No. 3) Regulation

2013 L.N.

98 of

2013 B2975 药剂业及毒药管理局 主席 陈汉仪

2013 年4月22 日Dr. Constance CHAN Chairman, Pharmacy and Poisons Board

22 April

2013 《2013 年药剂业及毒药 ( 修订 ) ( 第3号)规例》

2013 年第

98 号法律公告 B2976 注释 第1段Pharmacy and Poisons (Amendment) (No. 3) Regulation

2013 L.N.

98 of

2013 B2977 Explanatory Note Paragraph

1 注释 本规例在 《药剂业及毒药规例》 ( 第138 章,附属法例 A)( 《主体规 例》 ) 附表

1 的A分部及附表

3 的A分部中加入

3 种物质,使该 等物质的销售、供应、标签及贮存均受 《药剂业及毒药条例》 ( 第138 章)及《主体规例》 施加的限制所规限. Explanatory Note This Regulation adds

3 substances to Division A of the First Schedule and Division A of the Third Schedule to the Pharmacy and Poisons Regulations (Cap.

138 sub. leg. A) (principal Regulations) so that the sale, supply, labelling and storage of those substances are subject to the restrictions imposed under the Pharmacy and Poisons Ordinance (Cap. 138) and the principal Regulations.